Alvotech (ALVOW) Liabilities and Shareholders Equity (2020 - 2025)
Alvotech (ALVOW) reported Liabilities and Shareholders Equity of $1.5 billion for Q4 2025, up 21.75% on a YoY basis from $1.2 billion in Q4 2024, and up 5.53% quarter-over-quarter from $1.4 billion in Q3 2025.
Alvotech (ALVOW) Liabilities and Shareholders Equity (2020 - 2025) Analysis & Trends
Alvotech has reported Liabilities and Shareholders Equity for 6 years, with the latest figure at $1.5 billion in Q4 2025.
- For the quarter ending Q4 2025, Liabilities and Shareholders Equity rose 21.75% year-over-year to $1.5 billion; the trailing twelve-month figure through Dec 2025 stood at $5.5 billion (up 20.75% YoY), and the FY2025 full-year result was $1.5 billion, up 21.75% from the prior year.
- Liabilities and Shareholders Equity for Q4 2025 stood at $1.5 billion, up from $1.4 billion in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $1.5 billion in Q4 2025, with the low at $598.0 million in Q4 2021.
- Historically, Liabilities and Shareholders Equity has averaged $1.1 billion across 5 years, with a median of $1.1 billion in 2024.
- Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity jumped 38.54% — and 2025, when it advanced 14.29%.
- Alvotech's Liabilities and Shareholders Equity stood at $598.0 million in 2021, then jumped by 38.54% to $828.4 million in 2022, then advanced by 14.68% to $950.1 million in 2023, then increased by 28.56% to $1.2 billion in 2024, then increased by 21.75% to $1.5 billion in 2025.
- The last three Liabilities and Shareholders Equity figures came in at $1.5 billion (Q4 2025), $1.4 billion (Q3 2025), and $1.4 billion (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 40.04 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 15.15 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 6.71 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 555.95 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 4.91 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 13.22 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.26 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 2.27 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.35 Bn |
| 10 | Alvotech | - | - | -22.39 Mn | 1.49 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.49 Bn |
| Sep 30, 2025 | 1.41 Bn |
| Jun 30, 2025 | 1.39 Bn |
| Mar 31, 2025 | 1.25 Bn |
| Dec 31, 2024 | 1.22 Bn |
| Sep 30, 2024 | 1.23 Bn |
| Jun 30, 2024 | 1.07 Bn |
| Mar 31, 2024 | 1.06 Bn |
| Dec 31, 2023 | 950.09 Mn |
| Jun 30, 2023 | 910.66 Mn |
| Mar 31, 2023 | 895.47 Mn |
| Dec 31, 2022 | 828.44 Mn |
| Jun 30, 2022 | 774.50 Mn |
| Dec 31, 2021 | 597.98 Mn |
| Dec 31, 2020 | 474.42 Mn |